Effects of Glutamine in Ischemic Heart Disease Patients Following Cardiopulmonary Bypass

NCT01478126 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

24

Enrollment

NETWORK

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: N(2)-L-Alanine L-Glutamine dipeptide
DRUG: Placebo

Sponsor

Meshalkin Research Institute of Pathology of Circulation